Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company”) (NYSE: TARO) concerning possible violations of federal securities laws.
If you purchased shares of Taro and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
The investigation revolves around the September 9, 2016 announcement that Taro and two of its senior officers received grand jury subpoenas for a federal antitrust investigation into generic drug pricing. When this news was announced, shares of Taro dropped in value.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161019006616/en/
Contacts:
Joon M. Khang, Esq.
Telephone:
949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com
